ArticleInternational urology and nephrology2026
Burden of chronic kidney disease in India: past, present, and future projections to 2040 from the Global Burden of Disease 2021 Study.
Article in International urology and nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChronic kidney disease (CKD) is among the fastest-rising causes of mortality in India, yet national projections of its future burden are scarce. We quantified the current CKD burden and forecast trajectories to 2040 under alternative scenarios.
methodsUsing Global Burden of Disease (GBD) 2021 estimates, we assessed CKD outcome data. Projections to 2040 were generated under: (i) flat-rate (stable age-specific rates), (ii) trend (continuing average annual percent change from 2010-2021), and (iii) policy scenario (achieving risk factor control targets), with population forecasts from the Institute for Health Metrics and Evaluation.
resultsIn 2021, CKD caused 175,637 deaths (ASMR 12.4 per 100,000; 95% UI 10.4-14.9) and 6.49 million DALYs (ASDR 459 per 100,000; UI 393-534). Point prevalence was 128.0 million cases (9.3% of the population). In 2040, under flat-rate projections, CKD deaths will rise to 396,000 (UI 332,000-473,000) and DALYs to 14.6 million (UI 12.5-17.0 million) by 2040. In the trend scenario, deaths escalate to 556,000 (UI 465,000-671,000) and DALYs to 17.8 million (UI 15.4-20.7 million). By 2040, projected burden can be reduced by 15% if national diabetes and hypertension control targets are achieved.
conclusionBy 2040, CKD is projected to become a top-five cause of death in India, with mortality potentially exceeding half a million annually. The contrast between trend and policy scenarios highlights a substantial preventable burden. Strengthening diabetes and hypertension control, integrating an early CKD detection program, and ensuring equitable access to renal replacement therapy are urgently needed to bend the trajectory.
Indexed as
Identifiers
41484514What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.